Can a PSA bounce be seen shortly after SBRT to prostate cancer oligometastases while on androgen deprivation therapy?
I would not consider it a "bounce" if it happens shortly after treatment because the timing of a post-treatment bounce is later. If the PSA is higher than pre-treatment baseline soon after metastasis-directed SBRT, then you are likely observing one of two scenarios. First, the pre-treatment baseline was not updated in the setting of a short doubling time, and perhaps you missed getting a baseline near the peak. Alternatively, the post-treatment PSA is way too soon, and you are observing a PSA ri...
Join for free or sign in to see the full answer
I have seen a PSA bounce if the PSA is done sooner than 3 months, even while castrate. This is why I do not order a PSA until at least 3 months post any radiation, including to the primary or to metastatic sites.
Join for free or sign in to see the full answer
PSA bounces are more common in SBRT cases. They occur much later than most of us were taught; median of 14 months, i.e., beyond the three-month follow-up time points noted. This is, of course, extrapolated from localized treatment vs oligomets such as an excellent meta-analysis from Germany (Dejonckheere et al., PMID 39557124). Overall rate in this review indicated that it also occurs much more frequently, at 33% of cases. The interesting rationale for the bounce is that there is an infiltrating...
Join for free or sign in to see the full answer
Some additional commentary and a clarification on my comment to Dr. @Dr. First Last answer below:
The nuance here is about the target structure and purpose - for intact primary prostate treatment, I agree completely and have also noted these bounces. Literature traditionally describes bounces in a longer timeframe (9- 18 months), but it’s not clear whether PSAs were even checked sooner than 3 months post-treatment. However, I would be concerned about the case described regarding persistence/recu...
Join for free or sign in to see the full answer
Echoing the excellent points here, I think for a patient with known metastatic disease on ADT with rising PSA 3 months after SBRT is concerning.
I have seen bounces for mets directed RT in men who are using SBRT to delay or defer ADT at 3 months, but if testosterone is truly at castrate levels, then I would be concerned for progression.
I typically repeat PSA in a short interval and discuss options for repeat imaging vs considering next-line therapy. That could be ARSI, or it could be radioliga...
Join for free or sign in to see the full answer